Luxembourg Institute of Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Luxembourg Institute of Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9398
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ルクセンブルク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Luxembourg Institute of Health (LIH), formerly Centre de Recherche Public de la Sante is a biomedical research organisation that offers pre-clinical and clinical research in the areas of biomedicine and healthcare. The organization offers research under various departments such as infection and immunity, oncology, and population health. It also offers research support services including methodology and statistics, research knowledge transfer office, and doctoral training services. LIH’s business activities include generation of new disease mechanisms, diagnostics and treatments of human diseases; improve the understanding of health determinants and also the financial structures of health care. The organization also supports thematic research departments. It provides training and workshops for early-stage researchers. LIH is headquartered in Strassen, Luxembourg.

Luxembourg Institute of Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luxembourg Institute of Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Complix Raises US$15.5 Million In Series B Financing 10
Partnerships 12
WaferGen Biosystems Enters into Agreement with Luxembourg Institute of Health 12
University of Twente, Luxembourg Institute of Health and University of York Enter into Research Collaboration 13
iQur Enters into Co-Development Agreement with Six Consortium 14
Licensing Agreements 15
Advanced Biological Labs Enters Into Licensing Agreement With CRP-Sante For Comet Software 15
Luxembourg Institute of Health – Key Competitors 16
Luxembourg Institute of Health – Key Employees 17
Luxembourg Institute of Health – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
May 02, 2017: Treating cancer with viruses – Inauguration of a new binational research unit 19
Mar 09, 2017: The Cancer Foundation supports a project on cancer virotherapy of a newly created research group at LIH and DKFZ 20
Government and Public Interest 21
Apr 17, 2018: Luxembourg Institute of Health: Efficient control of leukaemia with treatment by dual immune-checkpoint blockade 21
May 17, 2017: Launch of the SYS-T-Act study: towards a personalised treatment of allergies 22
Apr 19, 2017: Master detox molecule boosts immune defence 23
Feb 28, 2017: FNR and LIH support Luxembourg research project on rare disease 24
Feb 01, 2017: LIH contributes to an important worldwide study on blood pressure with national data 25
Jan 16, 2017: Erasmus+ Award for a multinational project coordinated by LIH 26
Product News 27
Jan 10, 2017: Advancing brain tumour research with preclinical MRI studies 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Key Facts 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luxembourg Institute of Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luxembourg Institute of Health, Deals By Therapy Area, 2012 to YTD 2018 8
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Complix Raises US$15.5 Million In Series B Financing 10
WaferGen Biosystems Enters into Agreement with Luxembourg Institute of Health 12
University of Twente, Luxembourg Institute of Health and University of York Enter into Research Collaboration 13
iQur Enters into Co-Development Agreement with Six Consortium 14
Advanced Biological Labs Enters Into Licensing Agreement With CRP-Sante For Comet Software 15
Luxembourg Institute of Health, Key Competitors 16
Luxembourg Institute of Health, Key Employees 17
Luxembourg Institute of Health, Other Locations 18

List of Figures
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luxembourg Institute of Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Luxembourg Institute of Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ATI Physical Therapy:製薬・医療:M&Aディール及び事業提携情報
    Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy and healthcare services. The center offers therapy services such as hand therapy, women's health, workers' comp rehab, sports therapy, physical therapy, specialty therapies, home health and complimentary injury s …
  • Energisa SA (ENGI11):企業の財務・戦略的SWOT分析
    Energisa SA (ENGI11) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DNAtrix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • Novacyt SA (ALNOV):企業の財務・戦略的SWOT分析
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • InVitae Corp (NVTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Invitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and generates test reports for clinicians and their patients. The company’s portfolio of diagnostic t …
  • SNC-Lavalin Group Inc (SNC)-石油・ガス分野:企業M&A・提携分析
    Summary SNC-Lavalin Group Inc. (SNC) is global provider of engineering and construction services. It offers a range of engineering, procurement, construction, project management services to various industries, including oil and gas, mining and metallurgy, infrastructure and power. In addition, the c …
  • Societatea Nationala Nuclearelectrica SA (SNN):電力:M&Aディール及び事業提携情報
    Summary Societatea Nationala Nuclearelectrica SA (SNN) is a state owned power generating company. It generates nuclear power and heat using nuclear fission and also manufactures nuclear fuel. SNN is the only company producing electricity based on nuclear technology in Romania. It also produces nucle …
  • Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析
    Summary Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers co …
  • Acasti Pharma Inc (ACST):製薬・医療:M&Aディール及び事業提携情報
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Aker ASA (AKER)-石油・ガス分野:企業M&A・提携分析
    Summary Aker ASA (Aker) is an industrial investment company, which operates through in two areas, Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor A …
  • General Mills Inc:企業の戦略・SWOT・財務情報
    General Mills Inc - Strategy, SWOT and Corporate Finance Report Summary General Mills Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mitsui E&S Holdings Co., Ltd:企業の戦略・SWOT・財務分析
    Mitsui E&S Holdings Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui E&S Holdings Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • General Electric Co (GE):石油・ガス:M&Aディール及び事業提携情報
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services ranging from aircraft engines, power generation and oil and gas production equipment to medical …
  • SBM Offshore NV (SBMO)-石油・ガス分野:企業M&A・提携分析
    Summary SBM Offshore N.V. (SBM Offshore) is a floating production solutions provider for offshore oil and gas industry. The company designs supplies, installs and operates Floating Production, Storage and Offloading (FPSO) vessels. The company leases its FPSO vessels to its clients. It also undertak …
  • Mitsui E&S Holdings Co., Ltd. (7003):電力:M&Aディール及び事業提携情報
    Summary Mitsui E&S Holdings Co., Ltd. (Mitsui E&S) is a shipbuilding and engineering product manufacturing company. It has diversified business operations comprising environment recycling, construction of social infrastructure, advanced machinery systems, IT-related activities, ships and oceans, pla …
  • PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報
    Summary PT. SOHO Industri Pharmasi (PT SOHO), a subsidiary of SOHO Global Health, is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company’s products include analgesic, anti-inflammatory, antipyretic, antibiotics, antifungal, antihistamine a …
  • Outlook Therapeutics Inc (ONSIU):企業の財務・戦略的SWOT分析
    Summary Outlook Therapeutics Inc (Outlook Therapeutics), formerly Oncobiologics Inc, is a biopharmaceutical company that develops, manufactures and commercializes biosimilar products in the areas of ophthalmology. The company is investigating its lead product candidate, ONS-5010 an ophthalmic formul …
  • L’Oreal USA, Inc.:企業の戦略的SWOT分析
    L'Oreal USA, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • DiGi.Com Berhad (DIGI):企業の財務・戦略的SWOT分析
    DiGi.Com Berhad (DIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Orange Polska S.A.:企業の戦略・SWOT・財務情報
    Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆